The effects of different alkyl substitution on the structures and properties of poly(3-alkylthiophenes)

In order to investigate the influence of different alkyl side chain substitution on the structures and properties of P3ATs, X-ray diffraction, differential scanning calorimetry (DSC), thermal gravity analysis (TGA), Fourier transform infrared spectra (FTIR) and ultraviolet-visible spectra (W-VIS) were applied to characterizing the samples of ploy(3-octylthiophene) (P3OT), poly(3-dodecylthiophene) (P3DDT) and poly(3-octadecylthiophene) (P3ODT). It is found that the different length of alkyl group substitution leads to great difference in molecular chain packings, according to the room temperature X-ray diffraction results. The temperature dependence of X-ray diffraction experiments were also performed to study the melting processes of P3ATs. With the increase in the number of carbon atoms in alkyl side chains, the melting point decreases, and the thermal stability decreases too. The results of both FTIR and W-VIS spectra indicate that the conjugation length of P3DDT is the longest. among the three P3ATs. (C) 2001 Elsevier Science B.V. All rights reserved.

Gas permeability and permselectivity of polyimides prepared from phenylenediamines with methyl substitution at the ortho position

Polyimides were prepared from diamines: 2,4,6-trimethyl-1,3-phenylenediamine (3MPDA) and 2,3,4,5-tetramethyl-1,4-phenylenediamine (4MPDA). 1,4-Bis(3,4-dicarboxyphenoxy)benzene dianhydride (HQDPA), 3,3',4,4'-benzophenone tetracarboxylic dianhydride (BTDA), 3,3'-4,4'-diphenylsulphone tetracarboxylic dianhydride (SO(2)PDA), 3,3',4,4'-diphenylsulphide tetracarboxylic dianhydride (SPDA), pyromellitic dianhydride (PMDA), and 2,2'-bis(3,4-dicarboxyphenyl)hexa-fluoroisopropane dianhydride (6FDA) were used as dianhydride. The gas permeabilities of H-2, O-2 and N-2 through the polyimides were measured at temperatures from 30 degrees C to 90 degrees C. The results show that as methyl and trifluoromethyl substitution groups densities increase from 7.73 x 10(-3) molcm(-3) to 13.50 x 10(-3)molcm(-3), the peameability of H-2 increases 10-fold at 60% loss of permselectivity of H-2/N-2 however, the permeability of O-2 increases 20-fold at 20% loss of permselectivity of O-2/N-2. For O-2/N-2 separation, PMDA-3MPDA has similar performance to 6FDA-3MPDA and 6FDA-4MPDA; all have higher permeabilities for O-2 than normal polyimides, and the P(O-2)/alpha(O-2/N-2) trade-off relationships lie on the upper bound line for polymers. (C) 1999 Society of Chemical Industry.

THE EFFECT ON PHYSICAL-PROPERTIES OF THE SUBSTITUTION OF CA OR BA FOR SR IN NDSRNIO4

A new solid solution series, NdSr(1-x)M(x)NiO(4) (M = Ca: 0.0 less than or equal to x less than or equal to 1.0; M = Ba: 0.0 less than or equal to x less than or equal to 0.6), was synthesized by solid state reaction, and the structures, magnetic and electrical properties and optical spectra of this series have been studied. All the samples crystalized in tetragonal systems, with the exception of NdCaNiO4, which crystallized in the orthohombic system. IR spectra of NdSr1-xCaxNiO4 indicated that the lengths of two Ni-O bonds decrease with increasing Ca content. The electrical conduction changed from metallic-type to semiconductive-type when x greater than or equal to 0.4 (M = Ca, Ba), and the room temperature resistivities of NdSr1-xCaxNiO4 increased with the increase of Ca content. Magnetic susceptibility measurements revealed that Ni+3 ions in all the samplies were in low-spin state over the temperature range 77-300 K.

INTRAANNULAR AND INTERANNULAR SUBSTITUENT MIGRATION AND INTRAMOLECULAR IPSO SUBSTITUTION OF BIPHENYL DERIVATIVES IN MASS-SPECTROMETRY

Biphenyl derivatives undergo extensive intraannular substituent migrations and subsequent intramolecular ipso substitutions giving rise to a fluorenyl cation and a biphenylene radical cation as common products in mass spectrometry. For biphenyls bearing an alkyl group, interannular substituent migration resulting in a substituted tropylium ion is also observed. Electron-withdrawing groups are found to be much more favourable to these reactions than the electron-donating ones.

INFLUENCE OF THE SUBSTITUTION OF Y BY IN ON THE STRUCTURE AND MAGNETIC PROPERTY OF Y2CU2O5

In2CuO5 is isostructural to Y2Cu2O5 both in its crystal and magnetic structure. In and Y can be substituted by each other in any ratio to make new compounds Y2-xInxCu2O5 (x = 0-2) which were identified by XRD and IR spectrum. The structural change in Y2-x

INFLUENCE OF IONIC SUBSTITUTION ON THE MAGNETIC-BEHAVIOR OF Y2CU2O5

The influence of the substitution of Cu or O by various elements on the magnetic properties of Y2Cu2O5 has been studied. The substitution of Cu by metal ions with unpaired d electrons (M = Co2+, Ni2+) makes the superexchange in Cu2O8 chains stronger, but

CHEMICAL-IONIZATION MASS-SPECTROMETRY OF BENZOYL PEROXIDE - A RADICAL AROMATIC-SUBSTITUTION RESULTING IN BIPHENYLCARBOXYLIC ACID IN THE GAS-PHASE

A radical aromatic substitution resulting in biphenylcarboxylic acid is inferred for the decomposition of benzoyl peroxide from the chemical ionization and collision-induced dissociation mass spectra. The thermolysis of benzoyl peroxide gives rise to a benzoyloxy radical, which undergoes rapid decarboxylation and hydrogen abstraction leading to phenyl radical and benzoic acid, respectively. Attack of the resulting phenyl radical on the benzoic acid results in bipbenylcarboxylic acid. On the other hand, the phenyl radical abstracts a hydrogen atom to yield benzene, which is then subjected to the attack of a benzoyloxy radical, affording phenyl benzoate. This substitution reaction rather than the recombination of benzoyloxy and phenyl radicals is found to be responsible for the formation of phenyl benzoate under the present conditions.

Recovering a lost inheritance : The marital economy and its absence from the Prehistory of Economics in Britain

Roberts, Michael. 'Recovering a lost inheritance: the marital economy and its absence from the Prehistory of Economics in Britain', in: 'The Marital Economy in Scandinavia and Britain 1400-1900', (Eds) Argen, Maria., Erickson, Amy Louise., Farnham: Ashgate, 2005, pp.239-256 RAE2008

Construction of a Festuca pratensis BAC library for map-based cloning in IFestulolium substitution lines

Iain S. Donnison, Donal M. O Sullivan, Ann Thomas, Peter Canter, Beverley Moore, Ian Armstead, Howard Thomas, Keith J. Edwards and Ian P. King (2005). Construction of a Festuca pratensis BAC library for map-based cloning in Festulolium substitution lines. Theoretical and Applied Genetics, 110 (5) pp.846-851 Sponsorship: BBSRC;BBSRC RAE2008

Economics of new oncology drug development.

PURPOSE: Review existing studies and provide new results on the development, regulatory, and market aspects of new oncology drug development. METHODS: We utilized data from the US Food and Drug Administration (FDA), company surveys, and publicly available commercial business intelligence databases on new oncology drugs approved in the United States and on investigational oncology drugs to estimate average development and regulatory approval times, clinical approval success rates, first-in-class status, and global market diffusion. RESULTS: We found that approved new oncology drugs to have a disproportionately high share of FDA priority review ratings, of orphan drug designations at approval, and of drugs that were granted inclusion in at least one of the FDA's expedited access programs. US regulatory approval times were shorter, on average, for oncology drugs (0.5 years), but US clinical development times were longer on average (1.5 years). Clinical approval success rates were similar for oncology and other drugs, but proportionately more of the oncology failures reached expensive late-stage clinical testing before being abandoned. In relation to other drugs, new oncology drug approvals were more often first-in-class and diffused more widely across important international markets. CONCLUSION: The market success of oncology drugs has induced a substantial amount of investment in oncology drug development in the last decade or so. However, given the great need for further progress, the extent to which efforts to develop new oncology drugs will grow depends on future public-sector investment in basic research, developments in translational medicine, and regulatory reforms that advance drug-development science.